Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Medical Virology

• Publication date

  1998-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-9071(199804)54:4<256::AID-JMV4>3.0.CO;2-3PMID 9557291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon

  1998influential reference
• Factors Affecting Treatment Responses to Interferon-α in Chronic Hepatitis C

  1996cited by this paper
• Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C

  1996cited by this paper
• Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha

  1996cited by this paper
• Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

  1996cited by this paper
• The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy

  1996cited by this paper
• Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology

  1996cited by this paper
• Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing

  1995cited by this paper
• Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing.

  1995cited by this paper
• Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis.

  1995cited by this paper
• Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C

  1995cited by this paper
• Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations

  1995cited by this paper
• Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment

  1995cited by this paper
• Extrahepatic Immunologic Manifestations in Chronic Hepatitis C and Hepatitis C Virus Serotypes

  1995cited by this paper
• Hepatitis C virus in dermatology. A review.

  1995cited by this paper
• Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

  1995cited by this paper
• Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver

  1995cited by this paper
• To C or not to C: these are the questions.

  1995cited by this paper
• Hepatitis C Virus in Dermatology

  1995cited by this paper
• Single-strand conformation polymorphism study of human immunodeficiency virus type 1 RNA and DNA in plasma, peripheral blood mononuclear cells, and their virologic cultures.

  1995cited by this paper
• Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy.

  1995cited by this paper
• Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

  1994cited by this paper
• Genotypic analysis of hepatitis C virus in American patients

  1994cited by this paper
• Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA

  1994cited by this paper
• Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

  1994cited by this paper
• The red queen reigns in the kingdom of RNA viruses.

  1994cited by this paper
• RNA virus quasispecies: significance for viral disease and epidemiology.

  1994cited by this paper
• Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient.

  1994cited by this paper
• Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

  1993cited by this paper
• Detection of mutant sequences by single-strand conformation polymorphism analysis.

  1993cited by this paper
• Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

  1992influential reference
• Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

  1992cited by this paper
• The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

  1992cited by this paper
• RNA virus populations as quasispecies.

  1992cited by this paper
• Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

  1990cited by this paper
• Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

  1989cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

  1986cited by this paper

• Second hepatitis C virus transmission by blood components since introduction of mandatory NAT screening in Germany

  2022cites this paper
• Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients

  2021cites this paper
• Ceruloplasmin as a Predictor for Responsiveness to Direct Antiviral Drugs in Treatment of Chronic HCV Infection

  2019influential citation
• Fast estimation of genetic relatedness between members of heterogeneous populations of closely related genomic variants

  2018cites this paper
• Short interval change in hepatitis C hypervariable region 1 in chronic infection.Are there treatment windows in the envelope

  2016cites this paper
• Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome

  2014cites this paper
• Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV‐1 co‐infected patients

  2014cites this paper
• Phylogeny and molecular evolution of the hepatitis C virus.

  2014cites this paper
• Comparison of Quasispecies Diversity of HCV between Chronic Hepatitis C and Hepatocellular Carcinoma by Ultradeep Pyrosequencing

  2014cites this paper
• Mutações nos genes não estruturais do vírus da hepatite C associadas à resistência aos novos antivirais

  2014influential citation
• Novel Agents Inhibiting Hepatitis C Virus; Application to Prevention of Re-infection after Liver Transplantation

  2013cites this paper
• IMPACT OF NONSTRUCTURAL HEPATITIS C VIRUS ANTIGENS AND TOLL-LIKE RECEPTOR AGONISTS ON DENDRITIC CELL IMMUNOGENICITY

  2013cites this paper
• Genetic Variability of Bovine Viral Diarrhea Virus in Persistently Infected Cattle

  2013cites this paper
• Analysis of HCV quasispecies dynamic under selective pressure of combined therapy

  2013cites this paper
• Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.

  2013cites this paper
• Mutagenesis-Mediated Decrease of Pathogenicity as a Feature of the Mutant Spectrum of a Viral Population

  2012cites this paper
• Variability of hepatitis C virus hypervariable region 1 (HVR-1) during the early phase of pegylated interferon and ribavirin therapy.

  2012cites this paper
• New insights into the HCV quasispecies and compartmentalization.

  2011cites this paper
• Evolución del VIH-1 durante el proceso de recuperación de la eficacia biológica in vitro

  2011cites this paper
• Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics

  2011cites this paper
• New Insights into the HCV Quasispecies and Compartmentalization

  2011cites this paper
• Complexity and Catalytic Efficiency of Hepatitis C Virus (HCV) NS3 and NS4A Protease Quasispecies Influence Responsiveness to Treatment with Pegylated Interferon plus Ribavirin in HCV/HIV-Coinfected Patients

  2011cites this paper
• Mutant spectra in virus behavior

  2010cites this paper
• Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy

  2010cites this paper
• Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy

  2010cites this paper
• Innate immunity and hepatitis C virus: eluding the host cell defense.

  2009cites this paper
• The quasispecies nature and biological implications of the hepatitis C virus.

  2009cites this paper
• NS5AISDR‐V3 region genetic variability of Tunisian HCV‐1b strains: Correlation with the response to the combined interferon/Ribavirin therapy

  2009cites this paper
• Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C.

  2008cites this paper
• Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C.

  2008cites this paper
• Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C

  2008cites this paper
• Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit.

  2008cites this paper
• Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

  2008cites this paper
• Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

  2007cites this paper
• Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease.

  2007cites this paper
• Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4

  2007cites this paper
• Hepatitis C Hypervariable Region 1: Association of Reduced Selection Pressure in African Americans with Treatment Failure

  2007cites this paper
• Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.

  2007cites this paper
• Hepatitis C virus population dynamics during infection.

  2006cites this paper
• Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.

  2006cites this paper
• Evolution of Hepatitis C Virus Quasispecies in Children with Chronic Hepatitis C

  2006cites this paper
• Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation.

  2006cites this paper
• Plasma and Liver Hepatitis C Virus Variability in Patients Coinfected with Human Immunodeficiency Virus

  2006cites this paper
• Quasispecies as Predictive Response Factors for Antiviral Treatment in Patients with Chronic Hepatitis C

  2006influential citation
• Evolution of Hepatitis C Virus Quasispecies during Therapy with Il2 Combinated to Alpha Interferon and Ribavirin

  2005cites this paper
• HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.

  2005cites this paper
• Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection

  2005cites this paper
• Effect of Bottlenecking on Evolution of the Nonstructural Protein 3 Gene of Hepatitis C Virus during Sexually Transmitted Acute Resolving Infection

  2005cites this paper
• Identification of rare polymerase variants of hepatitis B virus using a two‐stage PCR with peptide nucleic acid clamping

  2004cites this paper
• Optimizing within-host viral fitness: infected cell lifespan and virion production rate.

  2004cites this paper
• HCV quasispecies evolution : association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV / HIV

  2004cites this paper
• Hepatitis C and fibrosis.

  2004cites this paper
• Host factors and failure of interferon-alpha treatment in hepatitis C virus.

  2004cites this paper
• Host factors and failure of interferon‐α treatment in hepatitis C virus

  2004cites this paper
• Hepatitis C virus genetic variability: pathogenic and clinical implications.

  2003cites this paper
• Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

  2003cites this paper
• Development of a hepatitis C virus vaccine.

  2003cites this paper
• CASE REPORT: Interferon-α for Reinfection with Hepatitis C Virus in Two Patients with Chronic Hepatitis C Who Had Responded to Previous Therapies

  2003cites this paper
• Predicting progression to cirrhosis in chronic hepatitis C virus infection

  2003cites this paper
• Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies.

  2003cites this paper
• OF DISEASE Host Factors and Failure of Interferon-Treatment in Hepatitis C Virus

  2003cites this paper
• Dynamic changes of HVR1 quasispecies in chronic hepatitis C after IFN therapy

  2003cites this paper
• Implications of Peginterferon Use in Special Populations Infected with HCV

  2003cites this paper
• Hepatitis C virus genetic variability in 52 human immunodeficiency virus‐coinfected patients

  2003influential citation
• Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus.

  2002cites this paper
• Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon‐α

  2002cites this paper
• Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels

  2002cites this paper
• [Physiopathology of HCV infection].

  2002cites this paper
• Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

  2002cites this paper
• Fibrosis and disease progression in hepatitis C

  2002cites this paper
• Impaired natural killer cell cytotoxic activity in chronic hepatitis C viral infection: A single-center, controlled study☆

  2002cites this paper
• [Treatment of patients with chronic hepatitis C who relapsed or did not respond to a previous treatment].

  2002cites this paper
• Traitement de l'hépatite C

  2002cites this paper
• Genetic Variability of Hepatitis C Virus in Dialysis: The Implications

  2002cites this paper
• Recent advances

  2002cites this paper
• Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.

  2002cites this paper
• Fibrosis and disease progression in hepatitis C

  2002cites this paper
• Rapid changes in hepatitis C virus quasispecies produced by a single dose of IFN-alpha in chronically infected patients.

  2001cites this paper
• Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy

  2001cites this paper
• Effect of HCV viral dynamics on treatment design: lessons learned from HIV

  2001cites this paper
• Hepatitis C Virus Genotyping: Clinical Implications and Methods

  2001cites this paper
• Longitudinal Evaluation of the Structure of Replicating and Circulating Hepatitis C Virus Quasispecies in Nonprogressive Chronic Hepatitis C Patients

  2001cites this paper
• Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy.

  2001cites this paper
• Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment

  2001cites this paper
• Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.

  2001cites this paper
• Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients.

  2001cites this paper
• Treatment of HCV-related Liver Disease in the Dialysis Population: A Novel Challenge for Clinical Nephrologists

  2001cites this paper
• Rapid Changes in Hepatitis C Virus Quasispecies Produced by a Single Dose of IFN-α in Chronically Infected Patients

  2001cites this paper
• Effect of HCV viral dynamics on treatment design: lessons learned from HIV.

  2001cites this paper
• Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment.

  2001cites this paper
• [Pegylated interferon: new progress in treatment for chronic hepatitis C].

  2000cites this paper
• The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon.

  2000cites this paper
• Genetic Heterogeneity of Hypervariable Region 1 of the Hepatitis C Virus (HCV) Genome and Sensitivity of HCV to Alpha Interferon Therapy

  2000cites this paper
• Nucleotide and Amino Acid Complexity of Hepatitis C Virus Quasispecies in Serum and Liver

  2000cites this paper
• Clinical significance of hepatitis C virus genotypes and quasispecies.

  2000cites this paper
• Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies

  2000cites this paper
• Interaction between the Hepatitis C Virus and the Immune System

  2000cites this paper
• Hepatitis C virus resistance to antiviral therapy

  2000cites this paper
• Methodological issues in papers on IFN therapy: time for reappraisal

  2000cites this paper
• Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy

  2000cites this paper